Global Virus Network Meeting Strengthens Ties Among Top Virus Researchers

GVN’s programs facilitate international collaborations to address growing viral threats

May 19, 2015, Beijing, China–The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working together to prevent illness and death from viral disease, held its 7th meeting in partnership with Beijing University of Technology, a GVN Center of Excellence, in Beijing, China May 16-19,2015. During a time of mass migration, global climate change and threats of remerging viruses such as Ebola, the timing and location of the meeting is of significant importance. Experts shared information on varying viral threats, including those causing hemorrhagic fevers, hepatitis, HIV, measles, influenza, dengue and chikungunya, to name a few. GVN members also reviewed strategies at the center of the organization including the creation of specialized task forces and the launch of training programs to address growing viral threats.

“We are pleased to have served as the catalyst for important scientific discussions and the inspiration for new international collaborations.”

“Professor Yi Zeng and his colleagues hosted an impressive, scientific meeting,” said Dr. Robert Gallo, Co-Founder and Scientific Director of the GVN. “The meeting provided an opportunity for leading experts to share cutting-edge research and stimulate difficult questions in an effort to solve some of the field’s top basic science and clinical challenges.”

“It is fitting for Beijing University of Technology to host many of the world’s top medical virologists as the University celebrates 55 years of success,” said Professor Yi Zeng, GVN China Center of Excellence Director. “We are pleased to have served as the catalyst for important scientific discussions and the inspiration for new international collaborations.”

GVN Centers of Excellence reviewed the effectiveness of strategies implemented by the network including the creation of international task forces and the use of technology to tackle today’s viral challenges.

For example, in 2014, GVN launched the Chikungunya Task Force in response to outbreaks spreading from Africa and Southeast Asia to North and South America. At the conference, GVN Task Force leaders discussed the spread of chikungunya around the world, current treatments and top prospects for vaccine candidates. GVN utilizes information technology such as a globally accessible webinar series to educate business leaders and media, among others, on viral threats such as chikungunya.

One topic of priority concern in both China and the U.S. is the re-emergence of measles. Dr. Diane Griffin at the Johns Hopkins Bloomberg School of Public Health shared updates on how the virus causes disease and how the measles vaccine offers protection against other infectious diseases. The protective value of the vaccine clearly establishes that vaccination policies should be rigorously implemented.

“In addition to the scientific exchanges, the GVN Centers of Excellence recommitted themselves to ensuring that the world is prepared against future pandemics by ensuring the training of tomorrow’s virology leaders,” said Dr. Sharon Hrynkow, President of the GVN. The GVN will host an intensive training course in medical virology in July, and invited Centers to send their best and brightest students to participate in the course, which includes world leaders as lecturers.

“We look forward to welcoming tomorrow’s medical virology leaders from around the world to Baltimore in July,” said Dr. Hrynkow.

Global Virus Network Meeting Strengthens Ties Among Top Virus Researchers

Global Virus Network Meeting Strengthens Ties Among Top Virus Researchers

GVN’s programs facilitate international collaborations to address growing viral threats Beijing, China, May 19, 2015:

Dr.Qing Ma, GVN President, Dr. Robert Gallo, Dr. Yi Zeng, Dr. Diane Griffin

The Global Virus Network (GVN), a coalition of the world’s leading medical virology
research centers working together to prevent illness and death from viral disease, held its 7th meeting in partnership with Beijing University of Technology, a GVN Center of Excellence, in Beijing, China May 16-19,2015. During a time of mass migration, global climate change and threats of remerging viruses such as Ebola, the timing and location of the meeting is of significant importance.  Experts shared information on varying viral threats, including those causing hemorrhagic fevers, hepatitis, HIV, measles, influenza, dengue and chikungunya, to name a few. GVN members also reviewed strategies at the center of the organization including the creation of specialized task forces and the launch of training programs to address growing viral threats.

“Professor Yi Zeng and his colleagues hosted an impressive, scientific meeting,” said Dr. Robert Gallo, Co-Founder and Scientific Director of the GVN. “The meeting provided an opportunity for leading experts to share cutting-edge research and stimulate difficult questions in an effort to solve some of the field’s top basic science and clinical challenges.”

“It is fitting for Beijing University of Technology to host many of the world’s top medical virologists as the University celebrates 55 years of success,” said Professor Yi Zeng, GVN China Center of Excellence Director. “We are pleased to have served as the catalyst for important scientific discussions and the inspiration for new international collaborations.”

GVN Centers of Excellence reviewed the effectiveness of strategies implemented by the network including the creation of international task forces and the use of technology to tackle today’s viral challenges.

For example, in 2014, GVN launched the Chikungunya Task Force in response to outbreaks spreading from Africa and Southeast Asia to North and South America. At the conference, GVN Task Force leaders discussed the spread of chikungunya around the world, current treatments and top prospects for vaccine candidates. GVN utilizes information technology such as a globally accessible webinar series to educate business leaders and media, among others, on viral threats such as chikungunya.

One topic of priority concern in both China and the U.S. is the re-emergence of measles. Dr. Diane Griffin at the Johns Hopkins Bloomberg School of Public Health shared updates on how the virus causes disease and how the measles vaccine offers protection against other infectious diseases. The protective value of the vaccine clearly establishes that vaccination policies should be rigorously implemented.

“In addition to the scientific exchanges, the GVN Centers of Excellence recommitted themselves to ensuring that the world is prepared against future pandemics by ensuring the training of tomorrow’s virology leaders, ” said the President of the GVN.  The GVN will host an intensive training course in medical virology in July, and invited Centers to send their best and brightest students to participate in the course, which includes world leaders as lecturers.

“We look forward to welcoming tomorrow’s medical virology leaders from around the world to Baltimore in July,” said GVN’s President.

Top Virologists Meet in China to Address Threats

Top Virologists of the Global Virus Network (GVN) Meet in China to Address Threats

The Addition of Two GVN Centers of Excellence Strengthen GVN’s Worldwide Reach

Baltimore, Maryland, USA, May 11, 2015: The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working together to prevent illness and death from viral disease, in partnership with Beijing University of Technology, a GVN Center of Excellence, will host its 7th meeting of top virologists May 16-19, 2015 in Beijing, China. The announcement was made today by Robert Gallo, MD, GVN Co-Founder and Scientific Director, Yi Zeng, MD, PhD, GVN China’s Center of Excellence Director and the GVN President. They also announced the addition of two new GVN Centers of Excellence including the University at Buffalo (UB), State University of New York (SUNY), USA and the Centre de Recerca en Sanitat Animal (CReSA), Barcelona, Spain. Since its founding in 2011, GVN has grown to include 34 Centers of Excellence in 24 countries, comprising expertise in all classes of human viruses.

“I am pleased to join my friend and colleague, Professor Yi Zeng, in hosting this important meeting as these personal, face-to-face interactions among our colleagues are integral to sharing information and inspiring international collaborations that otherwise might not exist,” said Dr. Robert Gallo, Director of the Institute of Human Virology at the University of Maryland School of Medicine, a GVN Center of Excellence. “China has been involved with GVN from the very inception, and Professor Yi Zeng has been and continues to be a valued and honored GVN leader as well as a member of the Scientific Leadership Board, which reviews all prospective Centers.“

“China is honored to host this meeting of the GVN,” said Professor Yi Zeng, Honorary Dean at the College of Life Sciences and Bioengineering at Beijing University of Technology and Chief Scientist and Professor at the Institute of Viral Diseases Control and Prevention China, a GVN Center of Excellence. “We are committed to working closely with our colleagues at the GVN and strengthening ties with the internationally renowned scholars who comprise the network.”

Members of the GVN will exchange ideas on viruses including HPV and Esophageal Carcinoma, Hepatitis, HIV/AIDS, emerging viruses, Measles, MERS, Dengue, Chikungunya, HTLV, Influenza, Hemorrhagic Fever viruses – including Ebola, among other viruses, and viral diagnostics. Other prominent virologists participating in the meeting include Dianne Griffin, MD, PhD of GVN’s Center of Excellence at Johns Hopkins Bloomberg School of Public Health, USA, who is a renowned measles expert and Ab Osterhaus, DVM, PhD, of GVN’s Center of Excellence at University of Veterinary Medicine, Germany, who is a renowned coronavirus expert (SARS, MERS). They will discuss many viral challenges China shares with other nations, including the rise of measles and the threat of coronaviruses.

“We are honored to be hosted in China, where the tradition of supporting virology in China is strong and the tradition of international cooperation stronger still,” added GVN’s President.   ”This meeting in China paves the way for onward collaborations and strengthening of our global safety net against viral disease threats. It is the first time that the GVN has met outside of the U.S. or Europe, and we are delighted to be in Asia.”

The GVN is an essential and critical defense against viral disease. It is a coalition comprised of world renowned virologists, all working to advance knowledge about how viruses cause disease, to develop drugs and vaccines to prevent illness and death, and to train the next generation of virus researchers. GVN is the only institution in the world that has expertise in all classes of human viruses.